IRMD vs WST
IRMD: A specialist medical device company providing the only known MRI-compatible non-magnetic IV infusion pumps and advanced patient vital signs monitoring systems for the magnetic resonance imaging environment. WST: Global leader in injectable drug containment and delivery systems serving biopharmaceutical and medical device manufacturers with primary packaging, drug delivery devices, and contract manufacturing.
Side-by-side fundamentals
| Metric | IRMD | WST | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $94.08 | $358.41 | |
| Market cap as of 2026-07-23 | $1.2B | $25.8B | |
| P/E as of 2026-07-23 | 51.42 | 47.55 | WST lower |
| PEG as of 2026-07-23 | 2.77 | 3.24 | IRMD lower |
| Net margin as of 2026-07-23 | +27.4% | +16.9% | IRMD higher |
| Gross margin as of 2026-07-23 | +76.8% | +36.3% | IRMD higher |
| Operating margin as of 2026-07-23 | +32.4% | +20.3% | IRMD higher |
| ROE as of 2026-07-23 | +24.5% | +17.9% | IRMD higher |
| ROA as of 2026-07-23 | +21.3% | +13.2% | IRMD higher |
| Debt / equity as of 2026-07-23 | 0.00 | 0.07 | IRMD lower |
| Revenue growth (YoY) as of 2026-07-23 | +14.8% | +11.2% | IRMD higher |
| Revenue CAGR (3y) SEC XBRL | +16.3% | +2.1% | IRMD higher |
| Dividend yield as of 2026-07-23 | +0.8% | +0.3% | IRMD higher |
| Dividend streak (yrs) SEC XBRL | 1 | 5 | WST higher |
| Beta as of 2026-07-23 | 0.92 | 1.12 | |
| 1-year return as of 2026-07-22 close | +69.0% | +63.7% | IRMD higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.